Effect of hyperhomocysteinemia on the protein kinase DYRK1A in liver of mice

Biochem Biophys Res Commun. 2009 Jan 16;378(3):673-7. doi: 10.1016/j.bbrc.2008.11.126. Epub 2008 Dec 6.

Abstract

Hyperhomocysteinemia due to cystathionine beta synthase (CBS)-deficiency confers diverse clinical manifestations, notably liver diseases. Even if hyperhomocysteinemia in liver of CBS-deficient mice, a murine model of hyperhomocysteinemia, promotes mitochondrial oxidative stress and pro-apoptotic signals, protective signals may counteract these pro-apoptotic signals, leading to chronic inflammation. As DYRK1A, a serine/threonine kinase, has been described as a candidate antiapoptotic factor, we have analyzed the expression of DYRK1A in liver of CBS-deficient mice. We found that DYRK1A protein level was reduced in liver of CBS-deficient mice, which was not observed at the gene expression level. Moreover, the use of primary hepatocytes/Kupffer cells co-culture showed that degradation of DYRK1A induced by hyperhomocysteinemia requires calpain activation. Our results demonstrate a deleterious effect of hyperhomocysteinemia on DYRK1A protein expression, and emphasize the role of hyperhomocysteinemia on calpain activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calpain / metabolism
  • Coculture Techniques
  • Cystathionine beta-Synthase / genetics
  • Disease Models, Animal
  • Dyrk Kinases
  • Enzyme Activation
  • Glycoproteins / pharmacology
  • Hepatocytes / enzymology
  • Hyperhomocysteinemia / enzymology*
  • Hyperhomocysteinemia / genetics
  • Kupffer Cells / enzymology
  • Liver / drug effects
  • Liver / enzymology*
  • Mice
  • Mice, Knockout
  • Protein Serine-Threonine Kinases / metabolism*
  • Protein-Tyrosine Kinases / metabolism*

Substances

  • Glycoproteins
  • calpain inhibitors
  • Protein-Tyrosine Kinases
  • Protein Serine-Threonine Kinases
  • Calpain
  • Cystathionine beta-Synthase